Impact on Family or Care-givers of Very Old ICU-survivors, Trajectories and 6 Months' Outcome in the Very Old.
NCT ID: NCT03138278
Last Updated: 2024-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2023-05-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis is that critical illness can be a large stressor to care-givers of survivors in the VIP measured as the occurrence and severity of the usual problems like PTSD and depression. The investigators hypothesize that a low-threshold on-line support program decreases the magnitude of anxiety, depression and PTSD for care-givers of very old intensive care patients (VIP) after discharge.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Caregiver Training: Evidence of Its Effectiveness for Cognitive and Functional Improvement in Older Adults
NCT04490070
A Support Program for Carers of Persons With Dementia
NCT01287767
Understanding the Lived Experience and Bereavement of Caregivers of People With Alzheimer's Disease
NCT07251738
Telephone Support for Dementia Caregivers
NCT00735800
Online Caregiver Psychoeducation and Support for Alzheimer's
NCT00416078
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Results from family/care givers experience: Degree of involvement with post-ICU care, impact on their own health (depression, PTSD, burden questionnaire)
* Effect of a simple intervention: on-line support and/or telephone advice on Return to pre-ICU frailty score (patients) and Occurrence of PTSD and depression in care-givers
* Information on 6 months' outcome (frailty and mortality) in very old survivors after ICU in different European countries
* Information on trajectories in the time after discharge: Dead/alive, home, nursing home, new hospital admissions, living with family/other care-givers, etc.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual care
ICU with ordinary care for elderly ICU survivors and their care-givers
No interventions assigned to this group
Telephone support
ICU with day-time telephone support to care-givers
Telephone support on demand
Dedicated phone number for help and advice for caregivers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telephone support on demand
Dedicated phone number for help and advice for caregivers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Society of Intensive Care Medicine
OTHER
University of Bergen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hans Flaatten
Professor emeritus and senior consultant R&D
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hans Flaatten, Prof
Role: PRINCIPAL_INVESTIGATOR
University of bergen; ESICM
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ESICM VIP2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.